Alnylam Pharmaceuticals Aktie
274,50
EUR
-8,90
EUR
-3,14
%
315,80
USD
-1,57
USD
-0,49
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung